Participants 73 118 4
childhood-onset obsessive-compulsive disorder
Participants 126 191 5
children with childhood-onset obsessive-compulsive disorder (OCD)
Participants 392 527 7
study examined the efficacy of riluzole, a glutamatergic modulator, as an adjunctive therapy for children with treatment-resistant OCD.
Participants 582 821 6
60 treatment-resistant children and adolescents (mean age=14.5 ± 2.4 years), with moderate to severe OCD (mean Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS)=28.2 ± 3.7), 17 of whom also had concomitant autism spectrum disord
Participants 944 994 4
. Fifty-nine subjects completed the randomized tri
Participants 1589 1622 3
r children with childhood-onset O
